Literature DB >> 25112229

Interventions to reduce inappropriate prescribing of antipsychotic medications in people with dementia resident in care homes: a systematic review.

Jo Thompson Coon1, Rebecca Abbott2, Morwenna Rogers2, Rebecca Whear2, Stephen Pearson3, Iain Lang2, Nick Cartmell4, Ken Stein2.   

Abstract

BACKGROUND: Antipsychotic medications are commonly used to manage the behavioral and psychological symptoms of dementia. Several large studies have demonstrated an association between treatment with antipsychotics and increased morbidity and mortality in people with dementia. AIMS: To assess the effectiveness of interventions used to reduce inappropriate prescribing of antipsychotics to the elderly with dementia in residential care.
METHOD: Systematic searches were conducted in 12 electronic databases. Reference lists of all included studies and forward citation searching using Web of Science were also conducted. All quantitative studies with a comparative research design and studies in which recognized methods of qualitative data collection were used were included. Articles were screened for inclusion independently by 2 reviewers. Data extraction and quality appraisal were performed by 1 reviewer and checked by a second with discrepancies resolved by discussion with a third if necessary.
RESULTS: Twenty-two quantitative studies (reported in 23 articles) were included evaluating the effectiveness of educational programs (n = 11), in-reach services (n = 2), medication review (n = 4), and multicomponent interventions (n = 5). No qualitative studies meeting our inclusion criteria were identified. Eleven studies were randomized or controlled in design; the remainder were uncontrolled before and after studies. Beneficial effects were seen in 9 of the 11 studies with the most robust study design with reductions in antipsychotic prescribing levels of between 12% and 20%. Little empirical information was provided on the sustainability of interventions.
CONCLUSION: Interventions to reduce inappropriate prescribing of antipsychotic medications to people with dementia resident in care homes may be effective in the short term, but longer more robust studies are needed. For prescribing levels to be reduced in the long term, the culture and nature of care settings and the availability and feasibility of nondrug alternatives needs to be addressed.
Copyright © 2014 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antipsychotic; care homes; dementia; prescribing behavior; systematic review

Mesh:

Substances:

Year:  2014        PMID: 25112229     DOI: 10.1016/j.jamda.2014.06.012

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  29 in total

1.  Concerns about quetiapine.

Authors:  Alan Garrity
Journal:  Aust Prescr       Date:  2015-12-01

2.  Interventions to Optimise Prescribing in Older People with Dementia: A Systematic Review.

Authors:  Leila Shafiee Hanjani; Duncan Long; Nancye M Peel; Geeske Peeters; Christopher R Freeman; Ruth E Hubbard
Journal:  Drugs Aging       Date:  2019-03       Impact factor: 3.923

3.  Association of a Communication Training Program With Use of Antipsychotics in Nursing Homes.

Authors:  Jennifer Tjia; Jacob N Hunnicutt; Laurie Herndon; Carolyn R Blanks; Kate L Lapane; Susan Wehry
Journal:  JAMA Intern Med       Date:  2017-06-01       Impact factor: 21.873

Review 4.  Interventions to Improve Medicines Management for People with Dementia: A Systematic Review.

Authors:  Mairead McGrattan; Cristín Ryan; Heather E Barry; Carmel M Hughes
Journal:  Drugs Aging       Date:  2017-12       Impact factor: 3.923

5.  Improvements in the prescribing of antipsychotics in dementia and psychogeriatric units in New Zealand.

Authors:  June M Tordoff; Nagham J Ailabouni; Dorothy P Browne; Hesham S Al-Sallami; Andrew R Gray
Journal:  Int J Clin Pharm       Date:  2016-05-30

Review 6.  Antipsychotic Use in Dementia.

Authors:  Julia Kirkham; Chelsea Sherman; Clive Velkers; Colleen Maxwell; Sudeep Gill; Paula Rochon; Dallas Seitz
Journal:  Can J Psychiatry       Date:  2016-10-08       Impact factor: 4.356

Review 7.  A systematic review of the outcomes reported in trials of medication review in older patients: the need for a core outcome set.

Authors:  Jean-Baptiste Beuscart; Lisa G Pont; Stefanie Thevelin; Benoit Boland; Olivia Dalleur; Anne W S Rutjes; Johanna I Westbrook; Anne Spinewine
Journal:  Br J Clin Pharmacol       Date:  2017-01-18       Impact factor: 4.335

Review 8.  Relationship between Organizational Culture and the Use of Psychotropic Medicines in Nursing Homes: A Systematic Integrative Review.

Authors:  Mouna Sawan; Yun-Hee Jeon; Timothy F Chen
Journal:  Drugs Aging       Date:  2018-03       Impact factor: 3.923

Review 9.  Evidence and decision algorithm for the withdrawal of antipsychotic treatment in the elderly with dementia and neuropsychiatric symptoms.

Authors:  Marta Miarons; Christopher Cabib; Francisco Javier Barón; Laia Rofes
Journal:  Eur J Clin Pharmacol       Date:  2017-08-05       Impact factor: 2.953

Review 10.  Clinical and Economic Outcomes of Interventions to Reduce Antipsychotic and Benzodiazepine Use Within Nursing Homes: A Systematic Review.

Authors:  Daniel J Hoyle; Ivan K Bindoff; Lisa M Clinnick; Gregory M Peterson; Juanita L Westbury
Journal:  Drugs Aging       Date:  2018-02       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.